2-Ethylhexanoic Acid

2-Ethylhexanoic Acid

SCHEMBL301319

CCCCC(CC)C(=O)O.CCCCC(CC)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 7/20 1.00
MAPK1 P28482 2/20 1.00
CA1 P00915 4/20 0.64
SLC1A2 P43004 3/20 0.61
SLC1A1 P43005 3/20 0.61
SLC1A3 P43003 2/20 0.61
CHRM1 P11229 1/20 0.56
AKR1A1 P14550 1/20 0.56
CHRM3 P20309 1/20 0.56
HTR2A P28223 1/20 0.56
HTR2C P28335 1/20 0.56
ADRA1A P35348 1/20 0.56
HRH1 P35367 1/20 0.56
DRD3 P35462 1/20 0.56
SLC6A3 Q01959 1/20 0.56
HDAC1 Q13547 1/20 0.56
HDAC2 Q92769 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
GRIK1 P39086 2/20 0.53
GRIK2 Q13002 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Ethylhexanoic Acid SCHEMBL8375903 1.00 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL6121661 1.00 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL5695779 1.00 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL282014 1.00 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL25800 1.00 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL8387406 1.00 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL5512393 1.00 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL25318625 0.98 CA2 (0.95) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL21054919 0.98 CA2 (0.95) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL21331330 0.98 CA2 (0.95) CA2MAPK1CA1SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220041937-A1 PROCESS FOR POLYMER MIXTURE HYDROCONVERSION ENI S.P.A. (IT) 2022-02-10 US claimed
EP-0884149-B1 Microbicidal agents LANXESS DEUTSCHLAND GMBH (DE) 2006-03-22 EP claimed
EP-1138388-B1 Catalytic composition for dimerisation, codimerisation and oligomerisation of olefins INST FRANCAIS DU PETROLE (FR) 2005-04-06 EP claimed
US-6706657-B2 USING COORDINATION CATALYST INSTITUT FRANCAIS DU PETROLE (FR) 2004-03-16 US claimed
EP-1122230-B1 Process for the selective dimerisation of propylene principally to ramified dimers INST FRANCAIS DU PETROLE (FR) 2003-06-25 EP claimed
US-20030109766-A1 Catalytic composition for dimerizing, co-dimerizing and oligomerizing olefins INSTITUT FRANCAIS DU PETROLE (FR) 2003-06-12 US claimed
US-6501001-B2 USING NICKEL COMPOUND OR COMPLEX INSTITUT FRANCAIS DU PETROLE (FR) 2002-12-31 US claimed
US-20010018546-A1 Process for selective dimerization of propylene principally into branched dimers INSTITUT FRANCAIS DU PETROLE (FR) 2001-08-30 US claimed
CN-109750523-B Synthetic leather and method for producing same DIC株式会社 2023-03-28 CN disclosed
CN-109791352-B Photosensitive resin composition, method for producing conductive pattern, substrate, touch panel, and display 东丽株式会社 2022-07-29 CN disclosed
US-20220041937-A1 PROCESS FOR POLYMER MIXTURE HYDROCONVERSION ENI S.P.A. (IT) 2022-02-10 US disclosed
US-10919849-B2 Online continuous flow process for the preparation of organic peroxides direct from alcohols or alkanes SHANGHAI HYBRID-CHEM TECHNOLOGIES (CN) 2021-02-16 US disclosed
CN-107849479-B Organometallic salt compositions, process for their preparation and lubricant additive compositions AB纳米技术公司 2021-02-02 CN disclosed
US-20200199068-A1 ONLINE CONTINUOUS FLOW PROCESS FOR THE PREPARATION OF ORGANIC PEROXIDES DIRECT FROM ALCOHOLS OR ALKANES SHANGHAI HYBRID-CHEM TECHNOLOGIES (CN) 2020-06-25 US disclosed
EP-0533016-A1 Water based, solvent- and emusifierfree microbicidal combination of active agents BAYER AG (DE) 1993-03-24 EP disclosed
EP-0522398-A1 Microbicidal compositions BAYER AG (DE) 1993-01-13 EP disclosed
EP-0522393-A1 Microbicidal compositions BAYER AG (DE) 1993-01-13 EP disclosed
EP-0510458-A1 Microbicidal compositions BAYER AG (DE) 1992-10-28 EP disclosed
EP-0048024-A1 Improved process for producing 1,3-bis(2-pyridylimino)isoindolines and compositions containing transition metal complexes thereof E.I. DU PONT DE NEMOURS AND COMPANY (US) 1982-03-24 EP disclosed
US-4255375-A CONTACTING AQUEOUS DISPERSION OF PIGMENT WITH ORGANIC ACID CIBA-GEIGY CORPORATION (US) 1981-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010018546-A1 Process for selective dimerization of propylene principally into branched dimers AP1M1, PHPT1, TAF1 CA2 1554/4885MAPK1 1497/4885CA1 1161/4885
US-10919849-B2 Online continuous flow process for the preparation of organic peroxides direct from alcohols or alkanes ADH1A, ADH1C, AOX1 CA2 2577/4885MAPK1 1470/4885CA1 2265/4885
US-20200199068-A1 ONLINE CONTINUOUS FLOW PROCESS FOR THE PREPARATION OF ORGANIC PEROXIDES DIRECT FROM ALCOHOLS OR ALKANES ADH1A, ADH1C, AOX1 CA2 2577/4885MAPK1 1470/4885CA1 2265/4885
US-20030109766-A1 Catalytic composition for dimerizing, co-dimerizing and oligomerizing olefins NOTUM, PHOSPHO1, ADH5 CA2 935/4885MAPK1 1854/4885CA1 165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.